Results 221 to 230 of about 356,092 (265)
Some of the next articles are maybe not open access.
Recombinant vaccinia virus vaccines
Trends in Biotechnology, 1988Vaccinia viruses have been genetically engineered to express foreign antigens. Immunization with these chimeric viruses protects experimental animals against challenge with the relevant infectious agent. These results, together with the successful history of vaccinia virus as an immunizing agent against smallpox, provide the impetus for employing live ...
James Tartaglia, Enzo Paoletti
openaire +1 more source
Genetic recombination with avian tumor virus
Virology, 1972A recombinant that has the transforming activity of a Rous sarcoma virus (helper-independent) and the subgroup specificity of an avian leukosis virus has been isolated from cells infected with these two types of virus. The temperature sensitivity of a sarcoma virus mutant was unaffected following alteration of the host range by recombination.
S, Kawai, H, Hanafusa
openaire +2 more sources
Recombinant Virus Bank for Gene Delivery
Science, 2005Viral vectors have been developed as therapeutic agents for the introduction of exogenous genes into living cells ([1][1]), and clinical trials of gene therapy and the use of viral vectors in the laboratory have been reported with increasing frequency during the past decade ([2][2]–[4][3 ...
Kazunari K, Yokoyama +9 more
openaire +2 more sources
Live Vaccinia Virus Recombinants Expressing Herpes Simplex Virus Genes
Clinical Infectious Diseases, 1991Vaccinia virus recombinants expressing antigens from herpes simplex virus (HSV) have been tested as potential live virus vaccines for prevention of HSV infection. We describe three vaccinia virus/HSV recombinants. The first expresses the HSV-1 glycoprotein D (vaccinia/gD), the second expresses the HSV-1 glycoprotein B (vaccinia/gB), and the third ...
J F, Rooney +3 more
openaire +2 more sources
Recombinant vaccinia virus vaccines
1989Vaccinia virus made a major contribution to world medicine as the live vaccine used to eradicate smallpox. Although smallpox vaccination has been discontinued, in the future vaccinia virus might be reused as a live vaccine but against other medical or veterinary pathogens.
openaire +1 more source
Cervical cancer prevention and control in women living with human immunodeficiency virus
Ca-A Cancer Journal for Clinicians, 2021Philip E Castle, Vikrant V Sahasrabuddhe
exaly
Current treatment and recent progress in gastric cancer
Ca-A Cancer Journal for Clinicians, 2021Smita S Joshi, Brian D Badgwell
exaly
Generation of Recombinant Adeno-Associated Virus
2003Adeno-associated virus (AAV) was discovered about 30 yr ago as a contaminant of adenovirus preparations. Since its discovery, researchers have described many unique characteristics of AAV biology that have made it attractive as a potential vector for gene therapy.
openaire +2 more sources
5093258 Recombinant fowlpox virus and recombination vector
Biotechnology Advances, 1992+4 more sources